Showing results 35 to 54 of 64
< previous
next >
| Issue Date | Title | Author(s) |
| 2011-11-01 | Palliative care of people with oesophageal cancer | Clark, K; Girgis, A; Currow, DC |
| 2023-10-12 | Participant Safety in Multisite, Randomized, Double-Blind, Placebo-Controlled Clinical Trials in Hospice/Palliative Care: Data from the Contracted Studies of the Australian National Palliative Care Clinical Studies Collaborative. | Currow, DC; Fazekas, B; Brown, L; Kochovska, S; Clark, K; Agar, MR |
| 2020-01-03 | Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone | Clark, K; Byrne, PG; Hunt, J; Brown, L; Rowett, D; Watts, G; Lovell, M; Currow, DC |
| 2015-01-01 | Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2012-10-01 | Pharmacovigilance in hospice/palliative care: Rapid report of net clinical effect of metoclopramide | Currow, DC; Vella-Brincat, J; Fazekas, B; Clark, K; Doogue, M; Rowett, D |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2022-02-07 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, B; Allcroft, P; Kochovska, S; Fujiwara, N; Miyaji, T; Lovell, M; Agar, M; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2016-12-01 | Physical Symptoms at the Time of Dying Was Diagnosed: A Consecutive Cohort Study to Describe the Prevalence and Intensity of Problems Experienced by Imminently Dying Palliative Care Patients by Diagnosis and Place of Care | Clark, K; Connolly, A; Clapham, S; Quinsey, K; Eagar, K; Currow, DC |
| 2013-05-01 | A pilot study to assess the feasibility of measuring the prevalence of slow colon transit or evacuation disorder in palliative care | Clark, K; Currow, DC |
| 2011-04-01 | Plain Abdominal Radiographs to Diagnose Constipation Patients with Advanced Progressive Illness? | Clark, K; Currow, DC |
| 2015-01-01 | The population burden of chronic symptoms that substantially predate the diagnosis of a life-limiting illness | Currow, DC; Clark, K; Kamal, A; Collier, A; Agar, MR; Lovell, MR; Phillips, JL; Ritchie, C |
| 2018-11-01 | A pragmatic comparative study of palliative care clinician’s reports of the degree of shadowing visible on plain abdominal radiographs | Clark, K; Lam, L; Talley, NJ; Watts, G; Phillips, JL; Byfieldt, NJ; Currow, DC |
| 2012-06-01 | The prevalence of bowel problems reported in a palliative care population | Clark, K; Smith, JM; Currow, DC |
| 2013-09-16 | Prospectively Collected Characteristics of Adult Patients, Their Consultations and Outcomes as They Report Breathlessness When Presenting to General Practice in Australia | Currow, DC; Clark, K; Mitchell, GK; Johnson, MJ; Abernethy, AP |
| 2012-01-01 | Re: Oral docusate in the management of constipation in hospice patients | Clark, K; Currow, DC |
| 2020-05 | Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23. | Clark, K; Currow, DC |
| 2011-11-01 | A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life | Sheehan, C; Clark, K; Lam, L; Chye, R |
| 2013-07-01 | The role of benzodiazepines in breathlessness: A single site, open label pilot of sustained release morphine together with clonazepam | Allcroft, P; Margitanovic, V; Greene, A; Agar, MR; Clark, K; Abernethy, AP; Currow, DC |
